Development of a Novel Fluorescent Recognition Guidewire System Toward Early Lung Cancer Biopsy
Open Access
- 21 July 2026
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (32) , e71473
Abstract
Obtaining tissue biopsies from peripheral pulmonary lesions remains challenging due to the limited maneuverability of conventional bronchoscopic instruments in distal airways and the inability to distinguish malignant from benign tissue in real time. Here, we present a proof‐of‐concept guidewire‐based biopsy system that integrates magnetic actuation for flexible navigation with fluorescence imaging for targeted lesion identification. The system comprises a magnetically driven biopsy tool, a miniaturized camera with an optical filter, a 488 nm laser fiber for fluorescence excitation, and a white‐light illumination fiber. Under external magnetic field control (10–40 mT), the system achieved a maximum deflection angle of 32.60° ± 1.03° (90° magnetic field) and successfully navigated through a scaled bronchial phantom to reach multiple target branches. Using FITC‐conjugated anti‐EGFR antibody‐labeled A549 cell spheroids as simulated tumor targets, the system demonstrated real‐time fluorescence identification and targeted biopsy, recovering 23.40% ± 2.63% of spheroid cells per sampling session. Navigation and biopsy capabilities were further validated in ex vivo porcine lungs. This integrated approach addresses both the navigation and target identification challenges inherent in peripheral lung biopsy and provides a foundation for future development toward clinical application.Keywords
Funding Information
- National Natural Science Foundation of China (52375560)
- Natural Science Foundation of Beijing Municipality (7252290)
This publication has 39 references indexed in Scilit:
- Metabolic Acidity/H2O2 Dual‐Cascade‐Activatable Molecular Imaging Platform Toward Metastatic Breast Tumor MalignancyAngewandte Chemie International Edition, 2024
- TIL Therapy in Lung Cancer: Current Progress and PerspectivesAdvanced Science, 2024
- Cell membrane targetable NIR fluorescent polarity probe for selective visualization of cancer cells and early tumorAnalytica Chimica Acta, 2023
- Adjuvant Treatments for Surgically Resected Non–Small Cell Lung Cancer Harboring EGFR MutationsJAMA Oncology, 2023
- A Millimeter‐Scale Soft Robot for Tissue Biopsy ProceduresAdvanced Intelligent Systems, 2023
- Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung CancerJAMA Oncology, 2023
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2020
- Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imagingBiomaterials, 2020
- An Activatable Nano‐Prodrug for Treating Tyrosine‐Kinase‐Inhibitor‐Resistant Non‐Small Cell Lung Cancer and for Optoacoustic and Fluorescent ImagingSmall, 2020
- Activatable Molecular Probes for Second Near‐Infrared Fluorescence, Chemiluminescence, and Photoacoustic ImagingAngewandte Chemie International Edition, 2020